Published in Front Pharmacol on May 07, 2014
Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories. Neuropathol Appl Neurobiol (2015) 0.96
Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver. World J Hepatol (2015) 0.95
Neuroferritinopathy: From ferritin structure modification to pathogenetic mechanism. Neurobiol Dis (2015) 0.94
Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients. Neurobiol Dis (2015) 0.91
Iron Homeostasis in Health and Disease. Int J Mol Sci (2016) 0.89
A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits. Neurobiol Dis (2014) 0.84
The clinical spectrum of inherited diseases involved in the synthesis and remodeling of complex lipids. A tentative overview. J Inherit Metab Dis (2014) 0.82
Gene co-expression networks shed light into diseases of brain iron accumulation. Neurobiol Dis (2015) 0.81
TECPR2 Associated Neuroaxonal Dystrophy in Spanish Water Dogs. PLoS One (2015) 0.80
Knock-down of pantothenate kinase 2 severely affects the development of the nervous and vascular system in zebrafish, providing new insights into PKAN disease. Neurobiol Dis (2015) 0.78
Lessons from a pair of siblings with BPAN. Eur J Hum Genet (2015) 0.77
The importance of iron in pathophysiologic conditions. Front Pharmacol (2015) 0.76
Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease. J Neurol Sci (2017) 0.76
"Pumping iron"-how macrophages handle iron at the systemic, microenvironmental, and cellular levels. Pflugers Arch (2017) 0.75
Coenzyme A corrects pathological defects in human neurons of PANK2-associated neurodegeneration. EMBO Mol Med (2016) 0.75
Mitochondrial dysfunction and defects in lipid homeostasis as therapeutic targets in neurodegeneration with brain iron accumulation. Rare Dis (2016) 0.75
Neuroferritinopathy: Pathophysiology, Presentation, Differential Diagnoses and Management. Tremor Other Hyperkinet Mov (N Y) (2016) 0.75
Effects of paternal cadmium exposure on the sperm quality of male rats and the neurobehavioral system of their offspring. Exp Ther Med (2015) 0.75
Clinical heterogeneity of PLA2G6-related Parkinsonism: analysis of two Saudi families. BMC Res Notes (2016) 0.75
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism. Microb Cell (2015) 0.75
Dietary strategies for improving iron status: balancing safety and efficacy. Nutr Rev (2017) 0.75
Ferrous Iron Up-regulation in Fibroblasts of Patients with Beta Propeller Protein-Associated Neurodegeneration (BPAN). Front Genet (2017) 0.75
Down-regulation of coasy, the gene associated with NBIA-VI, reduces Bmp signaling, perturbs dorso-ventral patterning and alters neuronal development in zebrafish. Sci Rep (2016) 0.75
Meta-analysis of the relationship between amyotrophic lateral sclerosis and susceptibility to serum ferritin level elevation. Neurosciences (Riyadh) (2016) 0.75
Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration. Mol Neurobiol (2016) 0.75
Network organization of the human autophagy system. Nature (2010) 11.38
Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med (2003) 6.47
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet (2001) 5.34
De novo mutations in the autophagy gene WDR45 cause static encephalopathy of childhood with neurodegeneration in adulthood. Nat Genet (2013) 4.71
Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet (2012) 3.80
Phospholipase A2 structure/function, mechanism, and signaling. J Lipid Res (2008) 3.46
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet (2001) 3.15
Infantile neuroaxonal dystrophy. J Neuropathol Exp Neurol (1963) 3.15
Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. Nature (1991) 3.10
Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J Med Genet (2008) 3.08
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet (2006) 2.97
Coenzyme A: back in action. Prog Lipid Res (2005) 2.62
A novel mechanism for the store-operated calcium influx pathway. Nat Cell Biol (2004) 2.61
Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology (2008) 2.57
Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol (2010) 2.48
ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov Disord (2010) 2.47
β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain (2013) 2.40
T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology (2008) 2.38
Genetics of neurodegeneration with brain iron accumulation. Curr Neurol Neurosci Rep (2011) 2.23
Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc Natl Acad Sci U S A (1999) 2.21
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc Natl Acad Sci U S A (2012) 2.16
Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci U S A (2004) 1.97
Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol Sci (2010) 1.94
Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol (2006) 1.86
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol (2004) 1.76
A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs. J Biol Chem (1997) 1.73
The WD40 repeat PtdIns(3)P-binding protein EPG-6 regulates progression of omegasomes to autophagosomes. Dev Cell (2011) 1.73
Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta (2011) 1.72
Male mice that do not express group VIA phospholipase A2 produce spermatozoa with impaired motility and have greatly reduced fertility. J Biol Chem (2004) 1.71
Mutations in the fatty acid 2-hydroxylase gene are associated with leukodystrophy with spastic paraparesis and dystonia. Am J Hum Genet (2008) 1.71
Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am J Hum Genet (2011) 1.70
Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity. J Biol Chem (1998) 1.67
Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration. Brain (2011) 1.66
Neuroaxonal dystrophy caused by group VIA phospholipase A2 deficiency in mice: a model of human neurodegenerative disease. J Neurosci (2008) 1.64
Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene (PLAN). Neurology (2008) 1.60
An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria. Hum Mol Genet (2003) 1.59
Biogenesis of iron-sulfur clusters in mammalian cells: new insights and relevance to human disease. Dis Model Mech (2012) 1.59
Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging (2010) 1.56
Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations. Am J Pathol (2008) 1.54
A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet (1995) 1.54
Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model. Brain (2013) 1.54
Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem (2003) 1.54
Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. J Neuropathol Exp Neurol (2005) 1.53
Calcium-independent phospholipase A(2): structure and function. Biochim Biophys Acta (2000) 1.53
Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology. Am J Pathol (2000) 1.52
Ca(2+)-independent cytosolic phospholipase A2 from macrophage-like P388D1 cells. Isolation and characterization. J Biol Chem (1994) 1.52
Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci (2002) 1.52
Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation. Brain (2006) 1.48
Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest Ophthalmol Vis Sci (2008) 1.47
Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci (2013) 1.46
Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). Hum Mutat (2010) 1.44
Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2. J Neurosci (2005) 1.44
Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia. Hum Mol Genet (2004) 1.44
The role of the L-chain in ferritin iron incorporation. Studies of homo and heteropolymers. J Mol Biol (1994) 1.43
Production and characterization of recombinant heteropolymers of human ferritin H and L chains. J Biol Chem (1993) 1.43
Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration. Ann N Y Acad Sci (2004) 1.42
Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum Mol Genet (2012) 1.41
Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage. Biochim Biophys Acta (2010) 1.39
Infantile neuroaxonal dystrophy: neuroradiological studies in 11 patients. Neuroradiology (1999) 1.37
The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration. Invest Ophthalmol Vis Sci (2011) 1.37
Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology (1987) 1.37
Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective. Biochem J (2002) 1.36
New NBIA subtype: genetic, clinical, pathologic, and radiographic features of MPAN. Neurology (2012) 1.35
Loss of iron triggers PINK1/Parkin-independent mitophagy. EMBO Rep (2013) 1.34
Calcium-independent phospholipase A2 localizes in and protects mitochondria during apoptotic induction by staurosporine. J Biol Chem (2006) 1.34
Function and inhibition of intracellular calcium-independent phospholipase A2. J Biol Chem (1997) 1.34
Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies. Acta Neuropathol (2000) 1.33
Deficiency of ATP13A2 leads to lysosomal dysfunction, α-synuclein accumulation, and neurotoxicity. J Neurosci (2012) 1.32
Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice. J Neurosci (2008) 1.30
Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol (1988) 1.30
Targeting chelatable iron as a therapeutic modality in Parkinson's disease. Antioxid Redox Signal (2014) 1.29
Activation of human mitochondrial pantothenate kinase 2 by palmitoylcarnitine. Proc Natl Acad Sci U S A (2007) 1.29
Hallervorden-Spatz disease: cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus. Ann Neurol (1985) 1.26
Absence of 2-hydroxylated sphingolipids is compatible with normal neural development but causes late-onset axon and myelin sheath degeneration. J Neurosci (2008) 1.24
Neuroferritinopathy: missense mutation in FTL causing early-onset bilateral pallidal involvement. Neurology (2005) 1.23
Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol (1995) 1.23
Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial. Mov Disord (2011) 1.21
Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein. J Biol Chem (2011) 1.19
fumble encodes a pantothenate kinase homolog required for proper mitosis and meiosis in Drosophila melanogaster. Genetics (2001) 1.19
Biochemical properties of human pantothenate kinase 2 isoforms and mutations linked to pantothenate kinase-associated neurodegeneration. J Biol Chem (2005) 1.18
Neuroferritinopathy in a Japanese family with a duplication in the ferritin light chain gene. Neurology (2008) 1.16
Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Anal Biochem (1999) 1.15
Neuroaxonal dystrophy in calcium-independent phospholipase A2β deficiency results from insufficient remodeling and degeneration of mitochondrial and presynaptic membranes. J Neurosci (2011) 1.14
De novo CoA biosynthesis is required to maintain DNA integrity during development of the Drosophila nervous system. Hum Mol Genet (2008) 1.14
Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene. J Neurochem (2009) 1.14
Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism. PLoS One (2010) 1.13
A novel ferritin light chain gene mutation in a Japanese family with neuroferritinopathy: description of clinical features and implications for genotype-phenotype correlations. Mov Disord (2009) 1.12
Localization and regulation of mouse pantothenate kinase 2. FEBS Lett (2007) 1.12
Palatal tremor and cognitive decline in neuroferritinopathy. J Neurol Neurosurg Psychiatry (2002) 1.11
PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Hum Mol Genet (2011) 1.11
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica (2011) 1.10
Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation. Am J Hum Genet (2013) 1.09
Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration. Proc Natl Acad Sci U S A (2010) 1.09
Germline deletion of pantothenate kinases 1 and 2 reveals the key roles for CoA in postnatal metabolism. PLoS One (2012) 1.08
Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J Biol Chem (2000) 1.08
Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6. Am J Pathol (2009) 1.08
Iron-mediated aggregation and a localized structural change characterize ferritin from a mutant light chain polypeptide that causes neurodegeneration. J Biol Chem (2008) 1.06
Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation. Brain (2008) 1.06
Central nervous system dysfunction in a mouse model of FA2H deficiency. Glia (2011) 1.05
Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology. Acta Neuropathol (2000) 1.04